Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia. | Br J Cancer | 2021 | 33082556 | PubTator, text mining | PubMed |
| Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies. | Biochem Biophys Res Commun | 2021 | 33069360 | PubTator, text mining | PubMed |
| Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion | Haematologica | 2021 | 33054121 | PubTator, text mining | PubMed |
| Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration. | Haematologica | 2021 | 33054118 | PubTator, text mining | PubMed |
| A Case of COVID-19-Induced Lymphocytosis in a Patient With Treatment-Naive CLL: Should It Be treated? | Clin Lymphoma Myeloma Leuk | 2021 | 33039356 | PubTator, text mining | PubMed |
| Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia. | Eur J Clin Invest | 2021 | 33022756 | PubTator, text mining | PubMed |
| STING regulates BCR signaling in normal and malignant B cells. | Cell Mol Immunol | 2021 | 32999453 | PubTator, text mining | PubMed |
| Reading the B-cell receptor immunome in chronic lymphocytic leukemia: revelations and applications. | Exp Hematol | 2021 | 32976948 | PubTator, text mining | PubMed |
| Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia. | Leukemia | 2021 | 32934355 | PubTator, text mining | PubMed |
| Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines. | Haematologica | 2021 | 32855274 | PubTator, text mining | PubMed |
| Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia. | Haematologica | 2021 | 32732360 | PubTator, text mining | PubMed |
| RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia. | Leukemia | 2021 | 32728184 | PubTator, text mining | PubMed |
| MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age. | Cold Spring Harb Perspect Med | 2021 | 32601132 | PubTator, text mining | PubMed |
| Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL). | Leukemia | 2021 | 32555297 | PubTator, text mining | PubMed |
| Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis. | Hematol Oncol Stem Cell Ther | 2021 | 32473105 | PubTator, text mining | PubMed |
| Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia. | Haematologica | 2021 | 32414849 | PubTator, text mining | PubMed |
| Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancers. | Haematologica | 2021 | 32381576 | PubTator, text mining | PubMed |
| Stem cell factor is implicated in microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia. | Haematologica | 2021 | 32336682 | PubTator, text mining | PubMed |
| Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicenter, open-label phase-II trial. | Haematologica | 2021 | 32107341 | PubTator, text mining | PubMed |
| Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia. | Haematologica | 2021 | 32079693 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=52